Moscow prosecutors are seeking to overturn Norilsk privatization

Article Abstract:

The article discusses how prosecutors in Russia are trying to overturn the privatization of Norilsk Nickel, a metals firm that was purchased by tycoon Vladmir Potanin in an allegedly rigged 1997 auction.

Asset sales & divestitures, Nonferrous Metals, Primary Metal Manufacturing, Management, Brief Article, Metal products, Potanin, Vladmir

---

Stillwater's holders clear Norilsk's offer

Article Abstract:

OAO Norilsk Nickel's acquisition bid for Stillwater Mining Co. has been approved by the latter's stockholders. Under the deal, Norilsk will acquire 51% of Stillwater.

United States, Metal industries, Metal industry, Metal industry software, Stillwater Mining Co., SWC

---

Xstrata raises bid for LionOre, topping Norilsk

Article Abstract:

U.K.-based Xstrata PLC increased its bid for Canada's LionOre Mining International Ltd. to $5.6 bil in an attempt to beat rival bidding by Russia's Norilsk Nickel. The new offer represents a premium of 16% per share.

United Kingdom, Strategy & planning, Primary nonferrous metals, not elsewhere classified, Mining & Extractive Industries, Mining, Metal ores, not elsewhere classified, All Other Metal Ore Mining, METAL MINING, Ferroalloy ores, except vanadium, Ferroalloy Ores, Chemical & Fertilizer Minerals, Other Nonmetallic Mineral Mining and Quarrying, Planning, Canada, Mining industry, Company business planning, Mineral industry, Nickel industry, LionOre Mining International Ltd., Xstrata PLC

Similar abstracts:

• Abstracts: Gucci enters agreement to acquire Boucheron from Schweizerhall. Gucci's YSL buys Mendes to aid brand
• Abstracts: Fenosa is given the green light to take over rival Cantabrico. Shareholders reject Fenosa's offer to buy Cantabrico
• Abstracts: Sonera Group's pretax earnings soar 12% on foreign businesses. Sonera's earnings rise 5.6%, helped by mobile business
• Abstracts: Solectron swings to net loss in quarter on lackluster sales. Solectron lowers its profit estimate for third quarter
• Abstracts: Pfizer to sell incontinence drug to defuse competition concerns. Elan shopping spree in U.S. nets Dura Pharmaceuticals

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.